Episode 6: Tomas Philipson – Free Riders and Price Controls: The Global Economics of Drug Innovation
In this episode, Tomas Philipson, a professor at the University of Chicago and former acting chair of the Council of […]
Episode 5: Tony Losasso – The Next Claritin? GLP-1 Drugs and the Future of Obesity Treatment
In this episode, Tony Losasso, a professor of economics and Driehaus Fellow at Depaul University, discusses his experiences in public
Episode 4: Doug Holtz-Eakin – Pharmaceutical Policy, Drug Pricing, and the Cost of Bad Policy
In EP4, Bryana Meyer joins us to talk with Doug Holtz-Eakin, former CBO head and president of the American Action
Episode 3: Marta Wosinska – Drug Shortages and How to Prevent Them
On this episode, Marta Wosinska of the Brookings Institution talks about drug shortages and the challenges of preventing them.
Episode 2: Karen Mandelbaum – CMS Privacy Standard for the Public Health Exchanges
In EP2, we interview Karen Mandelbaum at Epstein Becker Green and discuss her work at CMS drafting privacy standards for
Episode 1: Paul Howard – The Developing Role of AI Healthcare
In the first episode of On Background, we talk to Paul Howard, former senior advisor to the commissioner of the